SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-050130
Filing Date
2014-08-14
Accepted
2014-08-14 16:01:20
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v385533_10q.htm 10-Q 216062
2 EXHIBIT 31.1 v385533_ex31-1.htm EX-31.1 8261
3 EXHIBIT 31.2 v385533_ex31-2.htm EX-31.2 8161
4 EXHIBIT 32.1 v385533_ex32-1.htm EX-32.1 4110
5 EXHIBIT 32.2 v385533_ex32-2.htm EX-32.2 4148
  Complete submission text file 0001144204-14-050130.txt   2525018

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT asmb-20140630.xml EX-101.INS 275701
7 XBRL TAXONOMY EXTENSION SCHEMA asmb-20140630.xsd EX-101.SCH 35036
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20140630_cal.xml EX-101.CAL 17919
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20140630_def.xml EX-101.DEF 190735
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20140630_lab.xml EX-101.LAB 243892
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20140630_pre.xml EX-101.PRE 210112
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 141042528
SIC: 2834 Pharmaceutical Preparations